Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
暂无分享,去创建一个
P. Higgins | H. Sokol | Joel C. Joyce | L. Peyrin-Biroulet | L. Beaugerie | K. Katsanos | E. Toader | F. Magro | Anthony Lopez | Xavier Aldeger | Antónia Costa | Teresa Mas de Xaxars
[1] Gerard J Fitzsimmons,et al. From the Australian Institute of Health and Welfare , 2014, Communicable diseases intelligence quarterly report.
[2] Robert N. Anderson,et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels , 2013, Journal of the National Cancer Institute.
[3] F. Carrat,et al. Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[4] F. Carrat,et al. Risk of Melanoma in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Is Not Increased , 2012, The American Journal of Gastroenterology.
[5] W. Sandborn,et al. Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry , 2012, The American Journal of Gastroenterology.
[6] Christopher F. Martin,et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. , 2012, Gastroenterology.
[7] M. Durlik,et al. Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study , 2012, Virology Journal.
[8] D. Hunter,et al. Use of tanning beds and incidence of skin cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Harminder Singh,et al. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. , 2011, Gastroenterology.
[10] J. Hugot,et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. , 2011, Gastroenterology.
[11] Paul Emery,et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis , 2011, Annals of the rheumatic diseases.
[12] Harminder Singh,et al. Screening for cervical and breast cancer among women with inflammatory bowel disease: A population‐based study , 2011, Inflammatory bowel diseases.
[13] M. Candiani,et al. Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] Yongqiang Deng,et al. In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[15] Tao Zhang,et al. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia. , 2011, Rheumatology.
[16] E. Klumb,et al. Are women with lupus at higher risk of HPV infection? , 2010, Lupus.
[17] C. Porter,et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] N. Segnan,et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] J. Lear,et al. Non-melanoma skin cancer , 2010, The Lancet.
[20] U. Mercado. [Abnormal cervicovaginal cytology in women with rheumatoid arthritis]. , 2010, Ginecología y Obstetricia de México.
[21] C. Lees,et al. Lack of association between cervical dysplasia and IBD: A large case–control study , 2009, Inflammatory bowel diseases.
[22] C. Christodoulou,et al. Human papilloma viruses and cancer in the post-vaccine era. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[23] H. Sokol,et al. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle , 2009, Gut.
[24] C. Porter,et al. Suboptimal rates of cervical testing among women with inflammatory bowel disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[25] E. Kliewer,et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. , 2009, Gastroenterology.
[26] S. Allinson,et al. Cellular and sub-cellular responses to UVA in relation to carcinogenesis , 2009, International journal of radiation biology.
[27] A. Courtney,et al. The uptake of cervical cancer screening by renal transplant recipients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] J. Ferlay,et al. Incidence and mortality from non‐Hodgkin lymphoma in Europe: The end of an epidemic? , 2008, International journal of cancer.
[29] P. Karran,et al. PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients , 2008, British Journal of Cancer.
[30] D. Kemptner,et al. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis , 2008, BMC gastroenterology.
[31] S. Hutfless,et al. Screening differences and risk of cervical cancer in inflammatory bowel disease , 2008, Alimentary pharmacology & therapeutics.
[32] R. Panaccione,et al. Hepatosplenic T cell lymphoma in inflammatory bowel disease , 2008, Gut.
[33] M. Feltkamp,et al. Beta-papillomavirus infection and skin cancer. , 2008, The Journal of investigative dermatology.
[34] G. Williams. Antitumor necrosis factor-alpha therapy and potential cancer inhibition. , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[35] S. Kane,et al. Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.
[36] K. Aozasa,et al. Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein–Barr virus infection , 2008, Leukemia.
[37] D. van Baarle,et al. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients , 2008, Leukemia & lymphoma.
[38] T. M. Rünger. How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses. , 2007, The Journal of investigative dermatology.
[39] F. Baldanti,et al. Preemptive Therapy of EBV‐Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] J. Dillner,et al. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[41] Rachel E Neale,et al. Basal cell carcinoma on the trunk is associated with excessive sun exposure. , 2007, Journal of the American Academy of Dermatology.
[42] A. Halpern,et al. Melanoma survivorship: research opportunities , 2007, Journal of cancer survivorship : research and practice.
[43] S. Mannor,et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. , 2006, World journal of gastroenterology.
[44] Xavier Castellsagué,et al. Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.
[45] A. Iliadou,et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[46] H. Comber,et al. A population‐based study of skin cancer incidence and prevalence in renal transplant recipients , 2006, The British journal of dermatology.
[47] C. Meijer,et al. HPV‐mediated cervical carcinogenesis: concepts and clinical implications , 2006, The Journal of pathology.
[48] K. Ekström-Smedby,et al. Epidemiology and etiology of non-Hodgkin lymphoma – a review , 2006, Acta oncologica.
[49] B. Diffey,et al. Skin cancer incidence and the ageing population , 2005, The British journal of dermatology.
[50] C. Brensinger,et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine , 2005, Gut.
[51] Richard A Scolyer,et al. Cutaneous melanoma , 2005, The Lancet.
[52] D. Fan,et al. Regulation of apoptosis by the papillomavirus E6 oncogene. , 2005, World journal of gastroenterology.
[53] W. Mccune,et al. Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. , 2004, The Journal of rheumatology.
[54] H. Lorenz,et al. Basal Cell and Squamous Cell Carcinomas of the Skin , 2004 .
[55] P. Macpherson,et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. , 2004, Blood.
[56] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.
[57] H. Anton-Culver,et al. Etiologic Pathogenesis of Melanoma , 2004, Clinical Cancer Research.
[58] J. Nicolas,et al. Epstein-Barr Virus Viral Load in Crohn’s Disease: Effect of Immunosuppressive Therapy , 2004, Inflammatory bowel diseases.
[59] Frederick C Beddingfield. The melanoma epidemic: res ipsa loquitur. , 2003, The oncologist.
[60] H. Bartelink,et al. European Code Against Cancer and scientific justification: third version (2003). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[61] Diane Solomon,et al. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2003, Journal of lower genital tract disease.
[62] D. Berg,et al. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. , 2002, Journal of the American Academy of Dermatology.
[63] B. Cribier,et al. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype , 2002, The British journal of dermatology.
[64] X. Mariette,et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. , 2002, Blood.
[65] L. Naldi,et al. The epidemiology of skin cancer , 2002, The British journal of dermatology.
[66] C J L M Meijer,et al. The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.
[67] R. Graham-Brown,et al. Letter from the Editorial Team , 2002 .
[68] C. Brensinger,et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. , 2001, Gastroenterology.
[69] D. Parkin,et al. Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.
[70] A. Jemal,et al. Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.
[71] Jaap M Middeldorp,et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. , 2001, Blood.
[72] R. Stern,et al. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. , 2000, Archives of dermatology.
[73] K. Malinovszky,et al. Changing trends in non‐melanoma skin cancer in South Wales, 1988–98 , 2000, The British journal of dermatology.
[74] M. Peterson,et al. Increased cervical dysplasia in intravenous cyclophosphamidetreated patients with SLE: a preliminary study , 2000, Lupus.
[75] R. Stern,et al. Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.
[76] A. Zinsmeister,et al. Risk of lymphoma in inflammatory bowel disease. , 2000 .
[77] J. Kaldor,et al. Risk of cancer in people with AIDS. , 1999, AIDS.
[78] P. Buettner,et al. Incidence rates of skin cancer in Townsville, Australia , 1998, International journal of cancer.
[79] L Beardsley,et al. Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.
[80] W. Harmsen,et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. , 1997, Archives of dermatology.
[81] Bruce K. Armstrong,et al. Sunlight and cancer , 1997, Cancer Causes & Control.
[82] S. Rosso,et al. The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. , 1996, British Journal of Cancer.
[83] I. Penn. Cancers in cyclosporine-treated vs azathioprine-treated patients. , 1996, Transplantation proceedings.
[84] Pär Sparén,et al. HPV and cervical cancer , 2018 .
[85] P J Heenan,et al. A dose‐response curve for sun exposure and basal cell carcinoma , 1995, International journal of cancer.
[86] R. Westendorp,et al. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. , 1995, Gut.
[87] J. Soulé,et al. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. , 1994, The New England journal of medicine.
[88] M. Kamm,et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease , 1994, The Lancet.
[89] H. Adami,et al. Extracolonic malignancies in inflammatory bowel disease , 1991, Cancer.
[90] R. Carroll,et al. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.
[91] G. Rennie,et al. MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.
[92] F. J. Ensell,et al. ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.
[93] N. Hou,et al. Epidemiology and etiology of non-hodgkin lymphoma. , 2015, Cancer treatment and research.
[94] D. Porter,et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[95] J. Stockman. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2011 .
[96] H. Tilg,et al. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.
[97] K. Hemminki,et al. Cancer risks in Crohn disease patients. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[98] H. zur Hausen,et al. Papillomaviruses in the causation of human cancers - a brief historical account. , 2009, Virology.
[99] B. Thiers. Human Papillomavirus Infection and Incidence of Squamous Cell and Basal Cell Carcinomas of the Skin , 2007 .
[100] B. Thiers. The Photocarcinogenic Risk of Narrowband UVB (TL-01) Phototherapy: Early Follow-up Data , 2006 .
[101] A. Zinsmeister,et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. , 2002, Gastroenterology.
[102] Evan R. Myers,et al. Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic Review , 2001 .
[103] P Jensen,et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.
[104] R. Warnke,et al. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. , 1995, Leukemia & lymphoma.
[105] P. Morosini,et al. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. , 1995, European journal of gynaecological oncology.
[106] N. Segnan,et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. , 1993, European journal of cancer.
[107] N. Golden,et al. in Women with , 1992 .
[108] C. Boring,et al. Cancer statistics, 1990 , 1990, CA: a cancer journal for clinicians.
[109] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.